The trademark application GAMIDA CELL was filed by Gamida Cell Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 13, 2020, and it was registered by office on May 22, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 4, 2021. Appointment and Replacement of representative of the trademark registration was recorded on January 6, 2021.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Cell therapy preparations
Pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders.
The mark was filed in class 42 with Research and development in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders and providing medical and scientific research information in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders..